University of Utah
Radiation Oncology residency · Salt Lake City, UT · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Utah's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About University of Utahinstitution-wide radiation oncology research
Radiation Oncology publications from University of Utah and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
294
works per year
18th of 47 radiation oncology residency programs
+6.7%
2-year growth
30th of 47 radiation oncology residency programs
19.0%
in top 10% of field (works before 2025)
35th of 47 radiation oncology residency programs
40.3%
cited above world average
29th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 1,001Radiology, Nuclear Medicine and Imaging · 433
Radiation Oncology research topics at University of Utah
Papers in the window; each links to the list on OpenAlex.
- Cancer survivorship and care 124
- CAR-T cell therapy research 118
- Cancer Immunotherapy and Biomarkers 117
- Cutaneous Melanoma Detection and Management 101
- Colorectal Cancer Screening and Detection 99
- Corneal surgery and disorders 78
- Advanced MRI Techniques and Applications 61
- Global Cancer Incidence and Screening 61
Most cited at University of Utah since 2024
All radiation oncology papers there on OpenAlex
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta Kumar Pal et al. · Cancer Discovery · 2024 · PubMed · cited 173
- Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myelomaSurbhi Sidana et al. · Blood · 2024 · PubMed · cited 158
- Supramolecular Coordination Complexes for Synergistic Cancer TherapyYang Li et al. · Accounts of Chemical Research · 2024 · PubMed · cited 107
- Personalized Intervention Based on Early Detection of AtherosclerosisRikke Vibeke Nielsen et al. · Journal of the American College of Cardiology · 2024 · PubMed · cited 94
- Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation studySwaminathan P. Iyer et al. · The Lancet Oncology · 2024 · PubMed · cited 91
- Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power et al. · European Heart Journal · 2025 · PubMed · cited 90
- A NIR‐Light‐Activated and Lysosomal‐Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep‐Seated TumorsChonglu Li et al. · Angewandte Chemie International Edition · 2024 · PubMed · cited 66
- Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage DecisionRosita van den Puttelaar et al. · Gastroenterology · 2024 · PubMed · cited 66
- Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R. Cottrell et al. · Journal for ImmunoTherapy of Cancer · 2025 · PubMed · cited 61